DADE ACTIN FSL ACTIVATED PTT REAGENT B4219-2 SMN 10445714

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2016-05-12 for DADE ACTIN FSL ACTIVATED PTT REAGENT B4219-2 SMN 10445714 manufactured by Siemens Healthcare Diagnostics Products Gmbh.

Event Text Entries

[45100024] The cause of the reported incident, the administration of an extra dose of heparin is the discrepancy between therapeutic range values for heparinized patients between two facilities. There is no indication of erroneous results reporting by the complainant facility, (b)(6). This first facility follows the general recommendations for performing heparin therapeutic range testing with every change between old and new lots of aptt reagents and tracking the cumulative difference between lots. Siemens healthcare has provided the second facility, (b)(6), with the 2014 siemens white-paper on therapeutic heparin testing to evaluate their current practices. The actin fsl aptt reagent is performing within specifications. No further evaluation of the device is required.
Patient Sequence No: 1, Text Type: N, H10


[45100365] A change in treatment which occurred due to differences in activated partial thromboplastin time (aptt) heparin therapeutic ranges between two hospital facilities. A patient with an aptt result within the therapeutic range at the first facility was transferred to a second hospital facility. A medic involved in the transfer regarded the aptt result as low relative to the heparin therapeutic range at the second hospital facility. The patient was administered an extra dose of heparin based on the difference in therapeutic ranges. There is no indication that patient treatment was altered or prescribed on the basis of the difference in therapeutic ranges or the additional heparin dose administered. There was no report of adverse health consequences as a result of the difference in therapeutic ranges or the additional heparin dose administered.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9610806-2016-00018
MDR Report Key5651770
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2016-05-12
Date of Report2016-05-12
Date of Event2016-04-14
Date Mfgr Received2016-04-14
Device Manufacturer Date2015-07-02
Date Added to Maude2016-05-12
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationMEDICAL TECHNOLOGIST
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJAMES MORGERA
Manufacturer StreetGLASGOW BUSINESS COMMUNITY PO BOX 6101
Manufacturer CityNEWARK DE 197146101
Manufacturer CountryUS
Manufacturer Postal197146101
Manufacturer Phone3026318356
Manufacturer G1SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Manufacturer StreetEMIL VON BEHRING STRASSE 76
Manufacturer CityMARBURG, D-35041
Manufacturer CountryGM
Manufacturer Postal CodeD-35041
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameDADE ACTIN FSL ACTIVATED PTT REAGENT
Generic NameDADE ACTIN FSL ACTIVATED PTT REAGENT
Product CodeGGW
Date Received2016-05-12
Catalog NumberB4219-2 SMN 10445714
Lot Number547468A
Device Expiration Date2017-05-21
Device AvailabilityN
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH
Manufacturer AddressEMIL VON BEHRING STRASSE 76 MARBURG, D-35041 GM D-35041


Patients

Patient NumberTreatmentOutcomeDate
10 2016-05-12

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.